Inventor · disambiguated record
Erlinda M. Gordon
Also filed as: GORDON ERLINDA M · GORDON ERLINDA MARIA
26 granted patents·15 pending applications·177 citations·filing 1996–2022
96Inventor score
Files withUNIV SOUTHERN CALIFORNIA18HALL FREDERICK L8COUNTERPOINT BIOMEDICA LLC6GORDON ERLINDA M4DELTA NEXT GENE LLC3
Top patents by PatentIndex Score
41 records- 0192US7820157B2Transgene delivering retrovirus targeting collagen exposed at site of tissue injuryUNIV SOUTHERN CALIFORNIA·Filed 2008·Granted Oct 26, 2010·12 cites·3 claims
- 0288US7708986B2Targeted vectors for cancer immunotherapyUNIV SOUTHERN CALIFORNIA·Filed 2006·Granted May 4, 2010·6 cites·8 claims
- 0388US7347998B2Method of delivering therapeutic agents to site of tissue injuryUNIV SOUTHERN CALIFORNIA·Filed 2004·Granted Mar 25, 2008·19 cites·11 claims
- 0487US6410015B1Gene therapy methods using bone marrow-derived cells expressing blood clotting factorsUNIV SOUTHERN CALIFORNIA·Filed 2000·Granted Jun 25, 2002·21 cites·4 claims
- 0584US11325958B2Cyclin G1 inhibitors and related methods of treating cancerDELTA NEXT GENE LLC·Filed 2018·Granted May 10, 2022·2 cites·18 claims
- 0683US8530441B2Transgene delivering retrovirus targeting collagen exposed at site of tissue injuryHALL FREDERICK L·Filed 2012·Granted Sep 10, 2013·5 cites·12 claims
- 0781US7459541B2Matrix-targeted fusion polypeptides for tissue regeneration and wound healingUNIV SOUTHERN CALIFORNIA·Filed 2003·Granted Dec 2, 2008·17 cites·2 claims
- 0880US11273206B2Targeting of pharmaceutical agents to pathologic areas using bifunctional fusion polypeptidesCOUNTERPOINT BIOMEDICA LLC·Filed 2019·Granted Mar 15, 2022·1 cites·18 claims
- 0980US6864082B2Modified viral surface proteins for binding to extracellular matrix componentsUNIV SOUTHERN CALIFORNIA·Filed 2001·Granted Mar 8, 2005·9 cites·2 claims
- 1080US6825033B2Mutated cyclin G1 proteinUNIV SOUTHERN CALIFORNIA·Filed 2001·Granted Nov 30, 2004·9 cites·10 claims
- 1179US10981980B2Polypeptide targeting aptamers for characterization, capture, and clinical management of circulating tumor cellsCOUNTERPOINT BIOMEDICA LLC·Filed 2017·Granted Apr 20, 2021·1 cites·10 claims
- 1279US7605142B2Expression of cyclin G1 in tumorsUNIV SOUTHERN CALIFORNIA·Filed 2006·Granted Oct 20, 2009·2 cites·7 claims
- 1379US6387663B1Targeting pharmaceutical agents to injured tissuesUNIV SOUTHERN CALIFORNIA·Filed 1998·Granted May 14, 2002·40 cites·4 claims
- 1477US10913779B2Exposed collagen-targeted fusion cytokine for immune modulation in invasive cancers and lesions of infectionsCOUNTERPOINT BIOMEDICA LLC·Filed 2018·Granted Feb 9, 2021·1 cites·21 claims
- 1577US6955898B2Targeting pharmaceutical agents to injured tissuesUNIV SOUTHERN CALIFORNIA·Filed 2002·Granted Oct 18, 2005·9 cites·25 claims
- 1676US6277369B1Factor 1X delivery method using bone marrow-derived cellsUNIV SOUTHERN CALIFORNIA·Filed 2000·Granted Aug 21, 2001·6 cites·4 claims
- 1774US12173041B2Cyclin G1 inhibitors and related methods of treating cancerDELTA NEXT GENE LLC·Filed 2022·Granted Dec 24, 2024·0 cites·12 claims
- 1872US8148509B2Transgene delivering retrovirus targeting collagen exposed at site of tissue injuryHALL FREDERICK L·Filed 2010·Granted Apr 3, 2012·1 cites·7 claims
- 1972US8052966B2Methods and compositions for treating metastatic cancerUNIV SOUTHERN CALIFORNIA·Filed 2004·Granted Nov 8, 2011·5 cites·11 claims
- 2072US2015031625A1Targeted vectors for cancer immunotherapyUNIV SOUTHERN CALIFORNIA·Filed 2014·Application pending·0 cites
- 2169US7795023B2Identification of a pluripotent pre-mesenchymal, pre-hematopoietic progenitor cellUNIV SOUTHERN CALIFORNIA·Filed 2003·Granted Sep 14, 2010·3 cites·8 claims
- 2268US6844191B2Osteogenic cell growth using a TGFβ1-von Willebrand's factor fusion proteinUNIV SOUTHERN CALIFORNIA·Filed 2002·Granted Jan 18, 2005·2 cites·4 claims
- 2367US2022041696A1Polypeptide targeting aptamers for characterization, capture, and clinical management of circulating tumor cellsCOUNTERPOINT BIOMEDICA LLC·Filed 2021·Application pending·0 cites
- 2461US10420820B2Targeting of pharmaceutical agents to pathologic areas using bifunctional fusion polypeptidesCOUNTERPOINT BIOMEDICA LLC·Filed 2015·Granted Sep 24, 2019·0 cites·20 claims
- 2561US2022017586A1Exposed collagen-targeted fusion cytokine for immune modulation in invasive cancers and lesions of infectionsCOUNTERPOINT BIOMEDICA LLC·Filed 2021·Application pending·0 cites
- 2660US2023080185A1Damage-targeted treatments of diseaseDELTA NEXT GENE LLC·Filed 2022·Application pending·0 cites
- 2758US9017659B2Pathotropic targeted gene delivery system for cancer and other disordersHALL FREDERICK L·Filed 2007·Granted Apr 28, 2015·0 cites·7 claims
- 2858US2002177571A1Targeted vectors for cancer immunotherapyFiled 2001·Application pending·0 cites
- 2955US8828378B2Targeted vectors for cancer immunotherapyGORDON ERLINDA M·Filed 2010·Granted Sep 9, 2014·0 cites·6 claims
- 3055US2003086927A1Expression of cyclin G1 in tumorsUNIV SOUTHERN CALIFORNIA·Filed 2002·Application pending·0 cites
- 3153US2021346520A1Methods of using intravenous rexin-g: a tumor-targeted retrovector encoding a dominant-negative cyclin g1 (ccng1) inhibitor for advanced pancreatic cancerGORDON ERLINDA M·Filed 2021·Application pending·0 cites
- 3252US2009093407A1Matrix-targeted fusion polypeptides for tissue regeneration and wound healingHALL FREDERICK L·Filed 2008·Application pending·0 cites
- 3350US2007178066A1Pathotropic targeted gene delivery system for cancer and other disordersHALL FREDERICK L·Filed 2006·Application pending·0 cites
- 3450US2021299276A1Methods of exploiting oncogenic drivers along the human cyclin g1 pathway for cancer gene therapyGORDON ERLINDA M·Filed 2021·Application pending·0 cites
- 3550US2009123428A1Pathotropic targeted gene delivery system for cancer and other disordersHALL FREDERICK L·Filed 2008·Application pending·0 cites
- 3649US7078483B2Retroviral vectors including modified envelope escort proteinsUNIV SOUTHERN CALIFORNIA·Filed 2002·Granted Jul 18, 2006·0 cites·2 claims
- 3749US6063593ATGFβ1 responsive bone marrow derived cells to express a recombinant proteinUNIV SOUTHERN CALIFORNIA UNIVE·Filed 1996·Granted May 16, 2000·6 cites·16 claims
- 3849US2022184228A1Methods of promoting long-term survival of patients with advanced chemotherapy-resistant malignanciesGORDON ERLINDA M·Filed 2020·Application pending·0 cites
- 3945US2006292121A1Retroviral vectors including modified envelope escort proteinHALL FREDERICK L·Filed 2006·Application pending·0 cites
- 4044US2011052670A1Identification of a pluripotent pre-mesenchymal, pre-hematopoietic progenitor cellUNIV SOUTHERN CALIFORNIA·Filed 2010·Application pending·0 cites
- 4138US2012027727A1Targeted nanoparticles for cancer and other disordersHALL FREDERICK L·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Erlinda M. Gordon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →